Global p-Hydroxycinnamic Acid Market Outlook 2031

The global p-hydroxycinnamic acid market is anticipated to grow with a CAGR of 4.0% over the forecast period, i.e., 2022-2031. Factors such as growing application of p-hydroxycinnamic acid in various industries, followed by growing prevalence of obesity and diabetes are projected to drive the growth of the market growth in the coming years. Additionally, technology advancement in p-hydroxycinnamic acid, and also growing cosmetic industry are expected to boost the market growth. The market is estimated to garner a revenue of near to USD 190 Million by the end of 2031, up from a revenue of about USD 130 Million in the end of 2021.

The global p-hydroxycinnamic acid market is segmented into numerous segments, which include segmentation by product, and by end-user. By end-user the market is segmented into chemical industry, food industry, cosmetic industry, and pharmaceutical industry. By the end of 2031, the chemical industry segment is anticipated to garner the largest revenue of around USD 70 Million, up from a revenue of close to USD 50 Million.

On the basis of region, the global p-hydroxycinnamic acid market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in Asia Pacific amongst the market in all other regions is anticipated to garner the largest revenue of more than USD 80 Million by the end of 2031. Moreover, in the year 2021, the market in the region generated a revenue of over USD 50 Million.

Some of the prominent industry leaders in the global p-hydroxycinnamic acid market that are included in our report are Cayman Chemical, United States Biological Corporation Inc, Tokyo Chemical Industry Co., Ltd., AdooQ BioScience, Nanjing NutriHerb BioTech Co., Ltd, APExBIO Technology LLC, FujiFilm Wako Pure Chemical Co., BioCrick BioTech, Merck KGaA, MOLNOVA, and others.